期刊文献+

高苯丙氨酸血症患儿尿中代谢物水平分析 被引量:6

Analysis of urine metabolites levels in children with hyperphenylalaninemia
下载PDF
导出
摘要 目的通过检测高苯丙氨酸血症(HPA)患儿血苯丙氨酸(Phe)及尿苯丙酮酸、苯乙酸及苯乳酸水平,探讨其血Phe水平与尿代谢产物的关系。方法研究对象为55例HPA患儿,其中20例为轻度HPA(血Phe浓度〈360mmol/L)、35例为苯丙酮尿症(PKU,血Phe浓度360M200mmol/L);血r,he水平检测采用串联质谱干血滤纸片法;尿苯丙酮酸、苯乙酸及苯乳酸水平检测采用尿素酶预处理气相色谱-质谱法。结果HPA患儿血Phe水平与尿苯丙酮酸、苯乙酸及苯乳酸水平呈正相关(r=0.61~0.84,P均〈0.01)。轻度HPA与PKL噫儿尿苯丙酮酸、苯乙酸及苯乳酸水平差异有统计学意义(P均〈0.01);70%轻度HPA患儿及5.71%PKU患儿的尿苯丙酮酸、苯乙酸及苯乳酸水平正常。结论HPA患儿尿中苯丙酮酸、苯乙酸及苯乳酸水平的变化与血Phe浓度密切相关,单纯检测尿苯丙酮酸、苯乙酸及苯乳酸可能导致假阴性。 Objective To explore the relationship between blood phenylalanine (Phe) and urine metabolites by detection of blood Phe, urinary phenylpyruvate, phenyiacetate and phenyllactate levels in children with hyperphenylalaninemia (HPA) Methods Fifty-five children with hyperphenylalaninemia were selected, the level of Phe in the dried blood spot was tested by tandem mass spectrometry and urine levels of phenylpyruvate, phenylacetate and phenyllactate pretreated using urease were tested by gas chromatography mass spectrometry. Results Blood level of Phe and urine levels of phenylpyruvate, phenylac- etate and phenyllactate showed significant positive correlations (r=0.61-0.84, P〈0.01). For both blood level of Phe 360 mmol/ L and 360-1 200 mmol/L groups, rank tests showed significant differences among urine phenylpyruvate, phenylacetate and phenyllactate (P〈0.01); The normal number of children with urine levels of phenylpyruvate, phenylacetate and phenyllactate showed 14 cases (70%), 2 cases (5.71%), both was significantly different (P〈0.01). Conclusions The variation of urinary phe- nylpyruvate, phenylacetate and phenyllactate is correlated to blood Phe in children with HPA. However, it will lead to false negative result if the diagnosis made by detecting phenylpyruvate, phenylacetate and phenyllactate only.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2012年第12期1119-1121,共3页 Journal of Clinical Pediatrics
关键词 苯丙氨酸 苯丙酮酸 苯乙酸 苯乳酸 phenylalanine phenylpyruvate phenylacetate phenyllactate
  • 相关文献

参考文献11

  • 1Zytkovicz TH, Fitzgerald EF, Marsden D, et al. Tandem mass spectrometry analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Pro- gram [J]. Clin Chem, 2001, 47(11):1945-1955.
  • 2Han LS; Ye J, Qiu WJ, et al. Selective screening for in- born errors of metabolism on clinical patients using tan- dem mass spectrometry in China: a four-year report [J]. J Inherit Metab Dis, 2007, 30(4): 507-514.
  • 3Fu X, Iga M, Kimura M, eta1. Simplified screening for or- ganic acidemia using GC/MS and dried urine filter paper: a study on neonatal mass screening [J]. Early Hum Dev, 2000, 58(1): 41-55.
  • 4Kimura M, Yamamoto T, Yamaguchi S. Automated meta- bolic profiling and interpretation of GC/MS data for organ- ic academia screeing: a personal computer-based system [J]. Tohoku J Exp Med, 1999, 188 (4) : 317-334.
  • 5高晓岚,韩连书,叶军,邱文娟,顾学范.高苯丙氨酸血症患儿苯丙氨酸负荷试验后苯丙氨酸和酪氨酸浓度变化[J].临床儿科杂志,2004,22(8):509-512. 被引量:2
  • 6韩连书,叶军,邱文娟,高晓岚,王瑜,金晶,顾学范.串联质谱联合气相色谱-质谱检测遗传性代谢病[J].中华医学杂志,2008,88(30):2122-2126. 被引量:60
  • 7尚春庆,邓春晖,张平,胡耀铭.新生儿血液中的多种氨基酸及尿液中的苯丙酮酸和对羟基苯乙酸的GC/MS分析[J].复旦学报(自然科学版),2002,41(4):413-418. 被引量:2
  • 8罗小平,王慕逖,魏虹,梁雁,王宏伟,林汉华,董永绥,刘皖君,方俊敏,宁琴.尿滤纸片法气相色谱-质谱分析技术在遗传性代谢病高危筛查诊断中的应用[J].中华儿科杂志,2003,41(4):245-248. 被引量:115
  • 9Kitagawa T, Smith BA, Brown ES. Gas-liquid chromatogra- phy ofphenylalanine and its metabolites in serum and urine of various hyperphenylalaninemic subjects, their relatives, and controls [J]. Clin Chem, 1975, 21(6).. 735-740.
  • 10Michals K, Matalon R. Phenylalanine metabolites, atten- tion span and hyperactivity [J]. Am J Clin Nutr, 1985, 42(2): 361-365.

二级参考文献50

共引文献162

同被引文献59

  • 1彭月,李雪莲,银玲,韦正,刘友平.中药材硫熏法加工的研究现状及其二氧化硫残留检测方法[J].中药与临床,2012,3(5):5-8. 被引量:30
  • 2Syggelou A, Iacovidou N, Atzori L. Metabolomics in the deve- loping human being [J]. Pediatric Clinics of North America, 2012, 59 (5): 1039-1058.
  • 3Thayyil S, Chandrasekaran M, Taylor A, et al. Cerebral magnetic resonance biomarkers in neonatal encephalopathy: a meta analysis [J]. Pediatrics, 2010,125 ( 2 ) :e382-e395.
  • 4Camp KM, Parisi MA, Acosta PB, et al. Phenylketonuria scientific review conference: state of the science and future research needs [J]. Mol Genet Metab, 2014, 112(2) :87 - 122.
  • 5Blau N, van Spronsen FJ, Levy HI.. Phenylkemnuria[J]. I.tmcet, 2010, 376(97511) : 1417 - 1427.
  • 6Laryea MD, Herebian D, Meissner T, et al. Simultaneous LC- MS/ MS determination of phenylbutyrate, phenylaeetate be~xmte and their corresponding metabolites pheny|aeetylglutamine and hippurate in blood and urine[J], Inherit Metab Dis,2010,33(3) :321 - 328.
  • 7Rampini S, VoUmin JA, Bosshard HR,et al. A_n:anatie acids in urine of healthy infants, persistent hyperpherlylalaninemia, and phenylke- tonuria, before and after phenyalanine load[J]. Pediatr Res, 1974,8 (7) :704 - 709.
  • 8Sun Z, Ning Y, Liu L, et al. Metabolic engineering of the L- pheny- lalanine pathway in Escherichia coli for the production of S- or R- mandelie acid[J]. Mierob Cell Fact, 2011, 10:71.
  • 9van DE, Pretorius PJ, Impaired DNA repair and ganomie stability in hereditar'/tyrosinemia type 1 [J]. Gene, 2012,495 ( 1 ) : 56 - 61.
  • 10Pare CM, Sandier M, Stacey RS, 5 - hydroxytryptamine defieianey in phenylketonuria [J]. Lancet, 1957, 272(6968) :551 - 553.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部